A medical technique that involves safely hyperventilating conscious, unmedicated patients could facilitate the use of radiotherapy for cardiac ablation, according to research published in Frontiers in Physiology.
The FDA has approved Novo Nordisk’s Ozempic—once-weekly semaglutide—for an expanded indication of CV risk reduction in people with type 2 diabetes and established heart disease.
A study published in the latest edition of JACC: Cardiovascular Imaging suggests cardiac magnetic resonance imaging can be as effective as measurements of fractional flow reserve in evaluating nonculprit lesions after STEMI.
Rich people live an average of seven to nine more disability-free years than their socioeconomically disadvantaged peers, according to research published in the Journals of Gerontology: Medical Sciences Jan. 15.
Data released by the Centers for Disease Control and Prevention on Jan. 14 revealed that one in six cases of vaping-related lung illness, or EVALI, can be linked to legally purchased cannabis products.
Forty-two percent of physicians are burned out in 2020, according to Medscape’s annual National Physician Burnout & Suicide Report, and cardiologists fall in the top half of most-burned-out specialists.
Women’s blood vessels age at a faster rate than men’s, researchers from the Smidt Heart Institute at Cedars-Sinai reported this month—a finding that could explain some of the considerable sex gaps in CVD in men and women.
A cross-structural analysis published in Mayo Clinic Proceedings this January independently links diabetes to the development of heart failure, suggesting diabetic cardiomyopathy is a real—and growing—issue in the U.S.